Allison Swartz - 02 Mar 2026 Form 4 Insider Report for Progyny, Inc. (PGNY)

Reporting relationship: EVP, GC
Issuer ticker: PGNY
Reported as of: 02 Mar 2026
Net transaction value: -$119,007
SEC form: 4
Accepted by SEC: 04 Mar 2026, 17:31:56 UTC
Prior SEC filing: 08 Dec 2025
Next SEC filing: 06 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Mark Livingston, Attorney-in-Fact

Key filing fact

Allison Swartz filed Form 4 for Progyny, Inc. (PGNY) on 04 Mar 2026.

Key facts

This page summarizes Allison Swartz's Form 4 filing for Progyny, Inc. (PGNY).
7 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 04 Mar 2026, 17:31.

Change

Previous filing in this sequence was filed on 08 Dec 2025.
Current net transaction value: -$119,007.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001956339 Primary reporting owner

Swartz Allison

Relationship: EVP, GC
Address: C/O PROGYNY, INC., 1359 BROADWAY, 2ND FL, NEW YORK
Signature: /s/ Mark Livingston, Attorney-in-Fact
Signature date: 04 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PGNY transaction

Common Stock

Award

Transaction value
Shares: +28,409
Change %: +39%
Price: $0.000000^*
Shares after: 101,128
Date: 02 Mar 2026
Ownership: Direct
Footnotes: F1

PGNY transaction

Common Stock

Tax liability

Transaction value
Shares: -1,551
Change %: -1.5%
Price: $17.69^*
Shares after: 99,577
Date: 02 Mar 2026
Ownership: Direct
Footnotes: F2

PGNY transaction

Common Stock

Sale

Transaction value: $37,977
Shares: -2,199
Change %: -2.2%
Price: $17.27
Shares after: 97,378
Date: 02 Mar 2026
Ownership: Direct
Footnotes: F3

PGNY transaction

Common Stock

Tax liability

Transaction value
Shares: -2,842
Change %: -2.9%
Price: $17.60^*
Shares after: 94,536
Date: 03 Mar 2026
Ownership: Direct
Footnotes: F2

PGNY transaction

Common Stock

Sale

Transaction value: $8,698
Shares: -500
Change %: -0.53%
Price: $17.40
Shares after: 94,036
Date: 03 Mar 2026
Ownership: Direct
Footnotes: F3

PGNY transaction

Common Stock

Sale

Transaction value: $72,332
Shares: -4,157
Change %: -4.4%
Price: $17.40
Shares after: 89,879
Date: 03 Mar 2026
Ownership: Direct
Footnotes: F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PGNY transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares: +41,430
Change %
Price: $0.000000^*
Shares after: 41,430
Date: 02 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 41,430
Exercise price: $17.60
Footnotes: F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 4 footnotes

Footnote F1

Represents the number of shares of Issuer common stock underlying restricted stock units ("RSUs"). This was an annual merit grant made pursuant to the Issuer's 2019 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of Issuer common stock. 33% of the RSUs will vest on the first anniversary of the grant date, with the remainder vesting quarterly in installments thereafter through the third anniversary of the grant date, subject to the Reporting Person's continued service on each applicable vesting date.

Footnote F2

Shares withheld for payment of withholding taxes upon the vesting of restricted stock units granted to the Reporting Person.

Footnote F3

Shares sold pursuant to a Rule 10b5-1 trading plan entered into on May 13, 2025.

Footnote F4

Represents an annual merit grant made pursuant to the Issuer's 2019 Equity Incentive Plan. 33% of the shares will vest on the first anniversary of the grant date, with the remainder vesting quarterly in installments thereafter through the third anniversary of the grant date, subject to the Reporting Person's continued service on each applicable vesting date.